Loading organizations...
§ Venture Capital · Shanghai, Shanghai, China
VC/PE firm investing in AI, healthcare IT, biopharma, IT security, robotics, industrial machinery, and real estate startups.
Key people at Guoxin Venture Investment.
Guoxin Venture Investment is a venture capital and private equity firm based in Shijiazhuang, Hebei, China, with operations also associated with Shanghai. The firm invests in early-stage startups and growth companies across a diversified range of industries, including industrial machinery, IT security, real estate, artificial intelligence, robotics, healthcare IT, and biopharmaceuticals. It manages four private equity funds and has a registered capital of RMB 4 billion. Its portfolio includes notable companies such as Tiger Pharmaceuticals, Aier Ophthalmology, Dongcheng Pharmaceuticals, Lianyin Medical, and Lepu Medical. Guoxin Venture Investment is a wholly-owned subsidiary of Shanghai State-owned Assets Management Co. and recently participated in Evopoint's RMB 700 million Series E financing. The organization was established in March 2016, building on an earlier entity founded in 2000.
Key people at Guoxin Venture Investment.
Guoxin Venture Investment has 1 tracked investment across 1 company. The latest tracked deal is $33.0M Series C in IceKredit in November 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 24, 2020 | IceKredit | $33.0M Series C | Guoxin Venture Investment | China Creation Ventures, Guohe Capital, Yunqi Partners |